Anna D. Gvozdeva

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Statins and frailty prevention: true geroprotection or cardiovascular disease control?

Statins and frailty prevention: true geroprotection or cardiovascular disease control?

Journal: European heart journal

Published: September 01, 2026

Should Aspirin Be Discontinued in Patients Taking It for Primary Cardiovascular Prevention?

Should Aspirin Be Discontinued in Patients Taking It for Primary Cardiovascular Prevention?

Journal: Journal of the American Geriatrics Society

Published: March 06, 2026

The beneficial effect of heart rate-lowering therapy on mortality in post-myocardial infarction patients across the treatment eras.

The beneficial effect of heart rate-lowering therapy on mortality in post-myocardial infarction patients across the treatment eras.

Journal: European heart journal

Published: January 06, 2026

Left Ventricular Pericardial Strangulation: A Diagnostic Challenge in Acute Coronary Syndrome.

Left Ventricular Pericardial Strangulation: A Diagnostic Challenge in Acute Coronary Syndrome.

Journal: Methodist DeBakey cardiovascular journal

Published: November 19, 2025

Reversible Causes May Affect Outcomes of Medication Withdrawal Studies in Patients With Improved Ejection Fraction.

Reversible Causes May Affect Outcomes of Medication Withdrawal Studies in Patients With Improved Ejection Fraction.

Journal: JACC. Heart failure

Published: June 03, 2025

Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.

Traditional Chinese Medicine Compound and Clinical Outcomes in Acute Myocardial Infarction.

Journal: JAMA

Published: March 20, 2024

Comment on: Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients.

Comment on: Benefit of primary and secondary prophylactic implantable cardioverter defibrillator in elderly patients.

Journal: Clinical cardiology

Published: December 11, 2023

Comment on: Association between the beta-blockers, calcium channel blockers, all-cause mortality, and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.

Comment on: Association between the beta-blockers, calcium channel blockers, all-cause mortality, and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.

Journal: Clinical cardiology

Published: July 06, 2023

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction.

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction.

Journal: Journal of cardiovascular development and disease

Published: June 28, 2023

Left atrial dysfunction as the major driver of heart failure with preserved ejection fraction syndrome.

Left atrial dysfunction as the major driver of heart failure with preserved ejection fraction syndrome.

Journal: Journal of clinical ultrasound : JCU

Published: June 30, 2022

The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection Fraction.

The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection Fraction.

Journal: Kardiologiia

Published: September 02, 2020

Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world

Socio-economic burden of pulmonary hypertension: relevance of assessment in Russia and the world

Journal: Terapevticheskii arkhiv

Published: April 26, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026